Ha Tay Pharmaceutical Joint Stock Company
|
|
Sector:
Manufacturing
|
Industry:
Chemical - Pharmaceutical
|
|
87,000 
-600 (-0.68%)
03/26 08:19 End trading
|
Open
|
88,000
|
High
|
88,000
|
Low
|
87,000
|
Vol
|
12,186
|
Market Cap.
|
7,164
|
|
Remain Bid
|
140,914
|
Remain Ask
|
44,514
|
52Wk High
|
108,300
|
52Wk Low
|
25,700
|
52Wk Avg Vol
|
89,359
|
|
Foreign Buy
|
0
|
Frgn Owned(%)
|
41.02
|
Dividend
|
500
|
Dividend Yield |
0.01
|
Beta
|
0.68
|
|
EPS
|
875
|
P/E
|
100.11
|
F P/E
|
91.89
|
BVPS
|
12,834
|
P/B
|
6.78
|
|
|
|
|
1
day
| 5
days
| 3
months
| 6
months
| 12
months
|
|
|
|
|
|
|
History price
|
 |
Date | Price | Change | Volume | Avg. Buy | Avg. Sell | Foreign Buy | Foreign Sell |
26/03/25 |
87,000 |
-600 ▼(-0.68%)
| 12,186 | 2,126.39 | 700 | - | - |
25/03/25 |
87,600 |
-200 ▼(-0.23%)
| 15,304 | 2,293.85 | 540.43 | - | - |
24/03/25 |
87,800 |
-100 ▼(-0.11%)
| 16,315 | 2,195.95 | 534.27 | - | 1,000 |
21/03/25 |
87,900 |
-200 ▼(-0.23%)
| 15,731 | 2,452.17 | 639.33 | - | - |
20/03/25 |
88,100 |
+100 ▲(0.11%)
| 22,090 | 2,472.97 | 545.38 | - | 68 |
|
|
Financials
|
 |
|
|
|
|
Industry Peers |
 |
|
|
Symbol
|
Price
|
Vol
|
P/E
|
P/B
|
Mkt Cap
|
LAS
|
|
18,500 (-0.54%)
|
|
160,984
|
|
12.38
|
|
1.43
|
|
2,088
|
NET
|
|
81,500 (0.00%)
|
|
5,962
|
|
8.83
|
|
3.45
|
|
1,825
|
DP3
|
|
58,700 (0.51%)
|
|
30,300
|
|
10.32
|
|
2.43
|
|
1,262
|
PMC
|
|
116,000 (3.39%)
|
|
2,405
|
|
13.07
|
|
3.74
|
|
1,083
|
HVT
|
|
42,000 (0.96%)
|
|
16,508
|
|
5.43
|
|
1.01
|
|
461
|
|
News
|
|
|
|
Download documents
|
|
|
|
Overview
|
|
Contact
|
Listing Inf.
|
Business Reg.
|
Additional Inf.
|
Events
|
Notes
|
|
|
|
Name
|
Ha Tay Pharmaceutical Joint Stock Company |
English Name
|
Ha Tay Pharmaceutical Joint Stock Company |
Abbreviation
|
HATAPHAR
|
Address
|
10A Quang Trung Ha Dong Ha Noi |
Telephone (Tel)
|
(84.24) 3382 4685 |
Fax
|
(84.24) 3382 9054 |
Email
|
hataphar@fpt.vn
|
Website
|
https://www.hataphar.com.vn
|
Exchange
|
HNX |
Sector
|
Manufacturing |
Industry
|
Chemical - Pharmaceutical |
Listing date
|
12/03/2008 |
Chartered capital
|
823,417,730,000 |
Shares listed
|
82,341,773 |
Shares outstanding
|
82,340,260
|
Status
|
Operating |
Tax code
|
0500391400 |
Establishment License
|
1911/QĐ-UB |
Issued date
|
12/21/2000 |
Business license
|
0303000015 |
Issued date
|
01/10/2001 |
Main business scope
|
- Manufacturing and trading pharmaceutical products and materials, cosmetics, nutritional foods and medical equipment. - Exporting and importing pharmaceutical products, cosmetics, nutritional foods and medical equipment - Trading chemicals and testing chemicals. - Trading vaccines and healthcare products. - Other under business license. |
Branches
|
Branches: Address: 8/10/1 - Hoang Ngoc Phach - Lang Ha - Dong Da -Hanoi Tel: (84-04) 37763172 Fax: (84-04) 38311549
|
- 1965: Hatay Pharmaceutical Joint Stock Company, formerly Ha Tay Pharmaceutical Enterprise, was established. - 1985: Ha Tay Pharmaceutical Enterprise was merged with Ha Tay Pharmaceutical Company and Hoa Binh Pharmaceutical Material Company to set up Ha Son Binh Pharmaceutical Enterprise. - 1991: Ha Son Binh Pharmaceutical Enterprise was separated into Ha Tay Pharmaceutical Company and Hoa Binh Pharmaceutical Company. - 10 January 2001: Transformed into Ha Tay Pharmaceutical Joint Stock Company. - 2008: Company's stock was listed and traded on HNX. Initial charter capital is VND8.4 billion. - 01 July 2017: Charter capital was raised up to VND125,636,910,000. - 15 June 2018: Charter capital was raised up to VND188,447,720,000. - July 22, 2019: Increased charter capital to VND211.273.650.000; - April 27, 2021: Charter capital was raised up to VND264,088,280,000; |
22/12/2026 09:00
|
DHT Annoucement of the change of listing - 8,400,000 shares
|
Location
: Securities Companies
|
|
30/10/2024 09:00
|
DHT Dividend payment in cash with 5.00% (Tranche 1/2024) (Record date)
|
Location
: Securities Companies
|
|
30/10/2024 09:00
|
DHT Dividend payment in cash with 5.00% (Tranche 1/2024)
|
Location
: Securities Companies
|
|
Items
|
Unit
|
Price |
VND
|
Volume |
Shares
|
Foreigner's, Yield |
% |
Mkt Cap |
bVND
|
Financial indicators |
mVND |
EPS, BVPS, Dividend |
VND
|
P/E, F P/E, P/B
|
Times
|
ROS, ROA, ROE |
%
|
1. The accounting period for equitization year was calculated as of company's establishment date. 2. F PE bases on corporate earnings targets, which are announced by listed companies. 3. 3-month/6-month/12-month price charts was was compiled from revised data.
|
|
|
|
|
|
|
|